ClariTrial | Search Clinical Trials

Assessments of endocrinological phenotypes of LO-COCO patientsAssessment of muscular phenotypes of LO-COCO patientsAssessment of neuropsychiatric phenotypes of LO-COCO patients+6 more

Federico II University100 participants1 site · ItalyCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

Smartwatch-based Intervention for Cardiovascular Health (SWITCH)

N/APrehypertensionBorderline DyslipidemiaOverweight , Obesity

Smartwatch-Based Multi-Faceted Behavioral Intervention Model Led by Exercise and Dietary Interventions, Supported by Primary Medical Staff, Along with the Distribution of Health Education ManualsFace-to-face health education sessions

Beijing Anzhen Hospital1,400 participants3 sites · ChinaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

Who Will Benefit From Bariatric Surgery for Diabetes?

N/ADiabetes Mellitus, Type 2Obesity

Roux-en-Y gastric bypass (RYGB)

Imperial College London210 participants1 site · United KingdomCompletes Jan 2025

Compare CT.gov Full analysis →

1–15 of 732

Explore/diabetes obesity metabolic disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

732 results for “diabetes obesity metabolic disease” · Recruiting

Page 1 of 49

Recruiting

Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)

N/ADiabetes Mellitus

Hospital Regional de Alta Especialidad del Bajio500 participants1 site · MexicoCompletes Dec 2020

Compare CT.gov Full analysis →

Recruiting

Developmental Trajectories of Reinforcer Pathology and Childhood Obesity

N/APediatric Obesity

State University of New York at Buffalo250 participants1 site · United StatesCompletes Oct 2030

Compare CT.gov Full analysis →

Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Phase 3Atherosclerotic Cardiovascular DiseaseOverweightObesity

Maridebart CafraglutidePlacebo

Amgen12,800 participants781 sites · United States, Argentina, AustraliaCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

Phase 2Phase 3Myocardial InfarctionAcute Coronary SyndromeDiabetes

PlaceboDapagliflozin

University of Sao Paulo80 participants1 site · BrazilCompletes Jul 2025

Compare CT.gov Full analysis →

Recruiting

Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood Obesity

N/APediatric Obesity

Usual CareOnline community LITE programme

KK Women's and Children's Hospital100 participants1 site · SingaporeCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

N/AClassical Hodgkin LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Lifestyles Implemented-Survivorship Care Plan (LS-SCP)

Fondazione Italiana Linfomi - ETS552 participants40 sites · ItalyCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Early Phase 1Prostate CancerMetabolic SyndromeObesity

Apple Cider Vinegar

Western University30 participants1 site · CanadaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

N/AObesity & Overweight

Online Behavioral Obesity TreatmentFull Dietary Self-monitoringReduced-frequency Dietary Self-monitoring+3 more

The Miriam Hospital275 participants1 site · United StatesCompletes Mar 2029

Compare CT.gov Full analysis →

Recruiting

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Phase 2Electric Stimulation TherapyObesityWeight Loss

Transcranial Direct Current Stimulation (TDCS)Sham/no-stimulation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)148 participants1 site · United StatesCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Phase 4Metabolic Syndrome

Semaglutide, EmpagliflozinMinigastric bypassAnalimentary detoxication+1 more

University Medical Center, Kazakhstan220 participants1 site · KazakhstanCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Phase 2ObesityOverweightDiabetes Mellitus, Type 2

MacupatideEloralintideMacupatide Placebo+1 more

Eli Lilly and Company200 participants42 sites · United States, Argentina, AustraliaCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Phase 2Autosomal Dominant Polycystic KidneyObesity

TirzepatidePlacebo

University of Colorado, Denver126 participants1 site · United StatesCompletes Jun 2029

Compare CT.gov Full analysis →

Recruiting

LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

N/ALong Covid-19

Assessments of endocrinological phenotypes of LO-COCO patientsAssessment of muscular phenotypes of LO-COCO patientsAssessment of neuropsychiatric phenotypes of LO-COCO patients+6 more

Federico II University100 participants1 site · ItalyCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

Smartwatch-based Intervention for Cardiovascular Health (SWITCH)

N/APrehypertensionBorderline DyslipidemiaOverweight , Obesity

Beijing Anzhen Hospital1,400 participants3 sites · ChinaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

Who Will Benefit From Bariatric Surgery for Diabetes?

N/ADiabetes Mellitus, Type 2Obesity

Roux-en-Y gastric bypass (RYGB)

Imperial College London210 participants1 site · United KingdomCompletes Jan 2025

Compare CT.gov Full analysis →

1–15 of 732